Aardvark Therapeutics, Inc
Price
FilingsNewest: 8-K, Shareholder voteAug 17 →Insiders2 insiders bought $144,630 in 2 open-market buys. 1 insider sold $394,930, all 2 sales on a 10b5-1 plan.→HoldersDecheng Capital 17.9%Citadel 5.9%Laurion 4.7%→Financing →PeersClosest companies: TYRA, CAMP, ATAI→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$69.9Mlast 12 months
- Operating cash flow
- −$61.7Mlast 12 months
- Cash and equivalents
- $73.8Mat the last balance sheet
- Shares outstanding
- 21.9M shareson issue